OPGN: OpGen, Inc. Company Short-Term Debt

Symbol and logo of brand OpGen, Inc. (OPGN)

OpGen, Inc. (OPGN) business relies on stable demand within the biopharma sector, although sanctions and political risks complicate logistics and patenting. This daily price chart confirms the pressure, with the indicator standing at 0.00. OpGen, Inc. (OPGN) is implementing rapid pathogen analysis to combat resistant bacteria; however, due to the threat of default, operating cash flow has dried up, and the commercial potential of its diagnostic systems has been effectively destroyed.

OPGN (OpGen Inc) Company Short-Term Debts history from 07/04/2022 to 08/31/2024

Metric breakdowns and analytics for OpGen Corporation (OPGN)

- current quotes and average value forecast:
Price Chart OpGen|OPGN - Fair Value Consensus
- market capitalization information:
Market Value OpGen, Inc.|OPGN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share OpGen|OPGN - Book Capitalization|Market Cap to Net Assets Ratio opgen.com|OPGN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital OpGen, Inc.|OPGN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity OpGen, Inc.|OPGN - Company Aggregate Debt|Debts to Book Capitalization OpGen, Inc.|OPGN - Long-Term Liabilities|Company Short-Term Debts OpGen|Quick Ratio opgen.com
- net income and valuation multiples indicators:
OPGN - Net Income
Fundamental valuation:OpGen (OPGN)
Manufactured products of OpGen, Inc.

Logistics optimization for the delivery of diagnostic systems to hospital networks correlates directly with the short-term debt history of OpGen, Inc. (OPGN). This indicator aggregates all obligations maturing within one year, allowing investors to assess liquidity and the risk of working capital shortages, where the balance between borrowed funds and organic growth determines the business's financial stability.

Key competitors

SMMT - Company Short-Term Debt|Company Short-Term Loans and Borrowings MRNA (Moderna Inc)|Vaxcyte Corp (PCVX) - Company Short-Term Debt|Company Current Liabilities Tarsus Corp|CRMD (CorMedix Inc.) - Company Short-Term Debts|Company Short-Term Debts serestherapeutics.com|Company Current Liabilities SPRO (Spero Therapeutics, Inc.)|SCYX (scynexis.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ANTX (AN2 Therapeutics)|Short-Term Debt Volume PolyPid Ltd (PYPD)|LSB - Company Short-Term Debt|ITRM (Iterum Therapeutics plc) - Company Short-Term Indebtedness|PHGE: Company Short-Term Debts|Current Liabilities SNGX (Soligenix)|SXTP (60 Degrees Pharmaceuticals Inc.) - Company Short-Term Debts|Short-Term Debt oragenics.com OGEN|Company Short-Term Debts ONCO